Intramammary Preparation

Intramammary antibiotic cerate containing cefquinome for use in lactating cows. This product may only be prescribed by your local veterinary practitioner from whom advice should be sought. VPA 10996/105/001. Active ingredient: Cefquinome

Combiclav Lactating Cow Intramammary Suspension is specially formulated for the treatment of bovine mastitis. It contains Amoxicillin and Clavulanic Acid giving it a broad spectrum of bactericidal activity against the bacteria commonly found in the bovine udder. The prednisolone in Combiclav Lactating Cow Intramammary Suspension has an anti-inflammatory action which helps to reduce the potentially destructive swelling and inflammation associated with mastitis, without affecting the white cell response to infection. Dosage & Administration Combiclav Lactating Cow Intramammary Suspension should be administered at a dose rate of 3 syringes per infected quarter with a single syringe given every 12 hours. Use each syringe only once. Withdrawals • Milk for human consumption must not be taken from a cow during treatment. • With cows milked twice daily, milk for human consumption may only be taken from 84 hours after the last treatment. • Animals must not be slaughtered for human consumption during treatment. • Cattle may be slaughtered for human consumption only after 7 days from the last treatment.

Treatment of both the acute and chronic mastitis in cows during the lactation period caused by the pathogens sensitive to novobiocin penicillin dihydrostreptomycin and neomycin.Meat - 7 days milk – 72 hours (6 milking).

An antibiotic intramammary cerate containing cephapirin and prednisolone for use in lactating cows. This product may only be prescribed by your local veterinary practitioner from whom advice must be sought. Active ingredient: Cefapirin, Prednisolone

Multiject IMM is indicated in the treatment of acute and subacute bovine mastitis in milking cows, accompanied by pain and inflammation caused by bacterial infection sensitive to Penicillin, Streptomycin and Neomycin therapy. Active ingredient: Procaine Benzylpenicillin, Streptomycin Sulphate, Neomycin Sulphate, Prednisolone

For routine use in cows at drying off, to treat existing intramammary infections and to assist in preventing new infections occurring during the dry period. VPA 10959/008/001. Active ingredient: Neomycin, Penethamate, Procaine benzylpenicillin

Noroclox DC is an intramammary suspension formulated for use in the dairy cow at the point of drying off, that is immediately after the last milking of the lactation in order to treat existing mastitis and to provide protection against further infections during the dry period. Milk for human consumption must not be taken during treatment. Milk for human consumption may only be taken from 96 hours after calving. Not intended for use within 28 days of calving. If calving occurs before 28 days after the last treatment, milk for human consumption may only be taken from 28 days plus 96 hours after the last treatment. Active ingredient: Cloxacillin

Noroclox DC Xtra is formulated for use in cows at the point of drying off, that is, immediately after the last milking of the lactation, in order to treat existing mastitis and to provide prolonged protection against further infections during the dry period. Noroclox DC Xtra is a useful aid in reducing the incidence of summer mastitis in heifers and dry cows at risk. Formulated with a long- acting base and maintains effective antibacterial levels in the majority of quarters in dry cows for at least 7 weeks and is non-irritant to udder tissue.Not intended for use within 42 days of calving. Milk for human consumption may only be taken from 96 hours after calving. Should a cow calve earlier than 42 days after the last treatment, milk for human consumption may only be taken from 42 days plus 96 hours after last treatment. VPA 10999/065/001. Active ingredient: Cloxacillin

For the infusion of cows at drying off, to treat mastitis infections and to provide pretection against further infections during the dry period. One syringe per quarter following last milking before drying off. Withdrawal: Not intended for use within 42 days of calving. MILK: milk for human consumption may only be taken from 96 hours after calving, if calving occurs before 42 days milk should only be taken 42 days plus 96 hours after last treatment. MEAT AND OFFAL: 28 days. VPA 10019/032/001. Active ingredient: Cloxacillin Benzathine

For intrammary administration to lactating cattle for the single dose treatment of clinical mastitis. Inject syrine into infected quarter immediately after milking. Withdrawal:MILK: 72 hours, MEAT AND OFFAL: 2 days. Active ingredient: Cefoperazone

For treatment of udder infection in lactating cows caused by benzylpenicillin-susceptible staphylococci and streptococci. Dosage & Administration • For intramammary use: 3.0 g benzylpenicillin, procaine monohydrate per diseased udder quarter, corresponding to: one syringe per diseased quarter every 24 h for 3 consecutive days. • All udder quarters are to be carefully milked immediately prior to each administration. • After the teats and the teat tips have been cleaned and disinfected, one syringe is administered per infected udder quarter. • Withdrawals: Meat and offal: 5 days, Milk: 6 days

Prevention of ascending intramammary infections throughout the dry period Active ingredient: Bismuth subnitrate